| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 2971664 | The Journal of Heart and Lung Transplantation | 2011 | 7 Pages |
Abstract
The combination of complement components, HLA-DR and fibrin, is valuable in defining AMR in patients at risk for allograft loss from cardiovascular causes. Fibrin is particularly important for detecting the presence of severe AMR, with a high likelihood of poor long-term patient outcome.
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
Monica P. MD, Josef MD, Dylan MD, Gregory L. PhD, Melanie D. MD, Deborah MD, Feras M. MD, Rami A. MD, Edward M. MD, Bruce B. MD, Craig H. MD, M. Elizabeth H. MD, Abdallah G. MD,